In response to "Histopathologic validation of 3 '-deoxy-3 '-F-18-fluorothymidine PET for detecting tumour repopulation during fractionated radiotherapy in human FaDu squamous cell carcinoma in nude mice"

Esther G. C. Troost*, Bianca A. W. Hoeben, Peter Laverman, Jan Bussink, Wim J. G. Oyen

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)417-418
JournalRadiotherapy and Oncology
Issue number3
Publication statusPublished - Mar 2015

Cite this